Skip to main navigation Skip to search Skip to main content

Dose-ranging evaluation of intravitreal siRNA PF-04523655 for diabetic macular edema (the DEGAS study)

Quan Dong Nguyen, Ronald A Schachar, Chudy I Nduaka, Marvin Sperling, Anthony S Basile, Karen J Klamerus, Katherine Chi-Burris, Eric Yan, Dario A Paggiarino, Irit Rosenblatt, Roger Aitchison, Shai S Erlich, DEGAS Clinical Study Group

96 Citations (Scopus)

Abstract

To evaluate the safety and efficacy of three doses of PF-04523655, a 19-nucleotide methylated double stranded siRNA targeting the RTP801 gene, for the treatment of diabetic macular edema (DME) compared to focal/grid laser photocoagulation.
Original languageEnglish
JournalInvestigative ophthalmology & visual science
Volume53
Issue number12
Pages (from-to)7666-74
Number of pages9
ISSN0146-0404
DOIs
Publication statusPublished - 2012

Keywords

  • Adult
  • Aged
  • Aged, 80 and over
  • Diabetic Retinopathy
  • Dose-Response Relationship, Drug
  • Double-Blind Method
  • Female
  • Follow-Up Studies
  • Humans
  • Intravitreal Injections
  • Macula Lutea
  • Macular Edema
  • Male
  • Middle Aged
  • Prospective Studies
  • RNA, Small Interfering
  • Tomography, Optical Coherence
  • Treatment Outcome
  • Visual Acuity

Fingerprint

Dive into the research topics of 'Dose-ranging evaluation of intravitreal siRNA PF-04523655 for diabetic macular edema (the DEGAS study)'. Together they form a unique fingerprint.

Cite this